# MESA Treatment for NK/T Cell Lymphoma

> **NCT01933282** · PHASE2 · UNKNOWN · sponsor: **Air Force Military Medical University, China** · enrollment: 100 (estimated)

## Conditions studied

- Lymphoma, Extranodal NK-T-Cell

## Interventions

- **DRUG:** MESA chemotherapy
- **DRUG:** MESA

## Key facts

- **NCT ID:** NCT01933282
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933282, "MESA Treatment for NK/T Cell Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01933282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*